Skip to content
Certified ManufacturersFor manufacturers

PreMark Health Science, Inc.

Irving, TX, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

PreMark Health Science, Inc. is a dietary supplement manufacturer in Irving, TX, United States, certified to NSF/ANSI 455-2 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules and powders.

Facilities listed
1
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (1)

  • 3200 West Story Road, Irving, TX 75038, United States

    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Warehousing

How PreMark Health Science, Inc. compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

No food or dietary supplement recall found under the name PreMark Health Science, Inc. in FDA’s enforcement reports, as of .

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 6 food or dietary supplement inspections at facilities matching PreMark Health Science, Inc., from 2009 to 2022, as of . 3 found no objectionable conditions, 2 found conditions the firm was left to correct, and 1 led FDA to recommend official action.

  • No action indicated · No objectionable conditions found

    Inspected

    Irving, Texas

    FEI 3006709710

  • No action indicated · No objectionable conditions found

    Inspected

    Irving, Texas

    FEI 3006709710

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Irving, Texas

    9 citations posted:

    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Specifications - labels, packaging (21 CFR 111.70(d))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
    See all 9 citations
    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Specifications - labels, packaging (21 CFR 111.70(d))

      You did not establish label and packaging specifications.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity and composition of the finished dietary supplement.

    • Quality control - processes, specifications, written procedures (21 CFR 111.105(a))

      Your quality control personnel did not approve or reject specifications that may affect the identity, purity, strength, or composition of a dietary supplement.

    • Quality control operations - specifications; components, packaging, labels (21 CFR 111.120(b))

      Your quality control operations did not include determining whether components , packaging and labels conform to established specifications.

    • Quality control - components, approve, release (21 CFR 111.155(c)(3))

      Your quality control personnel did not approve components while the components were quarantined for use in the manufacture of a dietary supplement.

    • Standard reference materials; criteria for selecting, QC (21 CFR 111.315(d))

      Your laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations were not reviewed and approved by quality control personnel.

    • Examination, testing; appropriate (21 CFR 111.320(a))

      You did not verify that the laboratory examination and testing methodologies are appropriate for their intended use.

    • Label, packaging - discrepancies (21 CFR 111.410(b))

      You did not control the reconciliation of any issue and use label discrepancies.

    FEI 3006709710

  • No action indicated · No objectionable conditions found

    Inspected

    Irving, Texas

    FEI 3006709710

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Irving, Texas

    12 citations posted:

    • Manufacturing conditions (21 CFR 110.80(b)(2))
    • Written procedures - instruments, controls; calibrating (21 CFR 111.35(b)(1)(i))
    • Document-equipment date of use, maintain, clean, sanitize (21 CFR 111.35(b)(2))
    • Specifications - component identity (21 CFR 111.70(b)(1))
    See all 12 citations
    • Manufacturing conditions (21 CFR 110.80(b)(2))

      Failure to manufacture foods under conditions and controls necessary to minimize contamination.

    • Written procedures - instruments, controls; calibrating (21 CFR 111.35(b)(1)(i))

      You did not make and keep written procedures for calibrating instruments or controls that you use in testing a component or dietary supplement.

    • Document-equipment date of use, maintain, clean, sanitize (21 CFR 111.35(b)(2))

      You did not make and keep documentation of cleaning and sanitizing of the equipment.

    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    • Labels - quarantine; samples (21 CFR 111.160(c)(1))

      You did not collect representative samples of labels while the labels were quarantined.

    • Product received - quarantine; representative samples (21 CFR 111.165(c)(1))

      You did not collect representative samples of received product while the received product was quarantined.

    • Master manufacturing record - unique formulation (21 CFR 111.205(a))

      You did not prepare a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.

    • Batch record - complete (21 CFR 111.255(b))

      Your batch production record did not include complete information relating to the production and control of each batch.

    • Sampling plans; establish, follow (21 CFR 111.315(b))

      You did not follow sampling plans for obtaining representative samples.

    • Standard reference materials; criteria for selecting (21 CFR 111.315(d))

      You did not establish laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

    FEI 3006709710

Show all 6 inspections
  • No action indicated · No objectionable conditions found

    Inspected

    Irving, Texas

    FEI 3006709710

  • No action indicated · No objectionable conditions found

    Inspected

    Irving, Texas

    FEI 3006709710

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Irving, Texas

    9 citations posted:

    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Specifications - labels, packaging (21 CFR 111.70(d))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
    See all 9 citations
    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Specifications - labels, packaging (21 CFR 111.70(d))

      You did not establish label and packaging specifications.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity and composition of the finished dietary supplement.

    • Quality control - processes, specifications, written procedures (21 CFR 111.105(a))

      Your quality control personnel did not approve or reject specifications that may affect the identity, purity, strength, or composition of a dietary supplement.

    • Quality control operations - specifications; components, packaging, labels (21 CFR 111.120(b))

      Your quality control operations did not include determining whether components , packaging and labels conform to established specifications.

    • Quality control - components, approve, release (21 CFR 111.155(c)(3))

      Your quality control personnel did not approve components while the components were quarantined for use in the manufacture of a dietary supplement.

    • Standard reference materials; criteria for selecting, QC (21 CFR 111.315(d))

      Your laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations were not reviewed and approved by quality control personnel.

    • Examination, testing; appropriate (21 CFR 111.320(a))

      You did not verify that the laboratory examination and testing methodologies are appropriate for their intended use.

    • Label, packaging - discrepancies (21 CFR 111.410(b))

      You did not control the reconciliation of any issue and use label discrepancies.

    FEI 3006709710

  • No action indicated · No objectionable conditions found

    Inspected

    Irving, Texas

    FEI 3006709710

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Irving, Texas

    12 citations posted:

    • Manufacturing conditions (21 CFR 110.80(b)(2))
    • Written procedures - instruments, controls; calibrating (21 CFR 111.35(b)(1)(i))
    • Document-equipment date of use, maintain, clean, sanitize (21 CFR 111.35(b)(2))
    • Specifications - component identity (21 CFR 111.70(b)(1))
    See all 12 citations
    • Manufacturing conditions (21 CFR 110.80(b)(2))

      Failure to manufacture foods under conditions and controls necessary to minimize contamination.

    • Written procedures - instruments, controls; calibrating (21 CFR 111.35(b)(1)(i))

      You did not make and keep written procedures for calibrating instruments or controls that you use in testing a component or dietary supplement.

    • Document-equipment date of use, maintain, clean, sanitize (21 CFR 111.35(b)(2))

      You did not make and keep documentation of cleaning and sanitizing of the equipment.

    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    • Labels - quarantine; samples (21 CFR 111.160(c)(1))

      You did not collect representative samples of labels while the labels were quarantined.

    • Product received - quarantine; representative samples (21 CFR 111.165(c)(1))

      You did not collect representative samples of received product while the received product was quarantined.

    • Master manufacturing record - unique formulation (21 CFR 111.205(a))

      You did not prepare a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.

    • Batch record - complete (21 CFR 111.255(b))

      Your batch production record did not include complete information relating to the production and control of each batch.

    • Sampling plans; establish, follow (21 CFR 111.315(b))

      You did not follow sampling plans for obtaining representative samples.

    • Standard reference materials; criteria for selecting (21 CFR 111.315(d))

      You did not establish laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

    FEI 3006709710

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Irving, Texas

    11 citations posted:

    • Not washed/sanitized when appropriate (21 CFR 110.10(b)(3))
    • Floors, walls and ceilings (21 CFR 110.20(b)(4))
    • Safety lighting and glass (21 CFR 110.20(b)(5))
    • Cleaning and sanitizing operations (21 CFR 110.35(a))
    See all 11 citations
    • Not washed/sanitized when appropriate (21 CFR 110.10(b)(3))

      Employees did not wash hands thoroughly in an adequate hand-washing facility after each absence from the work station.

    • Floors, walls and ceilings (21 CFR 110.20(b)(4))

      The plant is not constructed in such a manner as to allow floors to be adequately cleaned and kept clean.

    • Safety lighting and glass (21 CFR 110.20(b)(5))

      Failure to provide safety-type lighting fixtures suspended over exposed food.

    • Cleaning and sanitizing operations (21 CFR 110.35(a))

      Failure to conduct cleaning and sanitizing operations for utensils and equipment in a manner that protects against contamination of food-contact surfaces.

    • Failure to clean - general (21 CFR 110.35(d))

      Failure to clean food-contact surfaces as frequently as necessary to protect against contamination of food.

    • Shown to be effective (21 CFR 110.35(d)(5))

      The procedure used for cleaning and sanitizing of equipment and utensils has not been shown to provide adequate cleaning and sanitizing treatment.

    • As source of contamination (21 CFR 110.37(b)(3))

      Plumbing constitutes a source of contamination to equipment and utensils.

    • Suitable locations (21 CFR 110.37(e)(1))

      Failure to provide hand washing facilities at each location in the plant where needed.

    • Precluding contaminants (21 CFR 110.40(a))

      The construction of equipment and utensils fails to preclude the adulteration of food with contaminants.

    • Storage (21 CFR 110.80(a)(1))

      Failure to store raw materials in a manner that protects against contamination.

    • Manufacturing conditions (21 CFR 110.80(b)(2))

      Failure to manufacture foods under conditions and controls necessary to minimize contamination.

    FEI 3006709710

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What PreMark Health Science, Inc. says it offers

From PreMark Health Science, Inc.’s own website, checked . Not verified by us.

Products

  • Herbal & botanicalShow quote“We expertly fill a wide array of powder-based vitamins, herbal formulas, and custom supplement blends, delivering reliable, consistent products that build customer trust and fuel your long term success.”
    “We expertly fill a wide array of powder-based vitamins, herbal formulas, and custom supplement blends, delivering reliable, consistent products that build customer trust and fuel your long term success.”

    Source page · seen on

  • Vitamins & mineralsShow quote“From vitamins and supplements, powder drink mixes, pet wellness, and seasoning mixes, we can bring your product to life!”
    “From vitamins and supplements, powder drink mixes, pet wellness, and seasoning mixes, we can bring your product to life!”

    Source page · seen on

  • Pet supplementsShow quote“Innovative production and packaging options make us a go-to source for pet dietary supplements, with specialty additives to mitigate the effect of aflatoxins in canines.”
    “Innovative production and packaging options make us a go-to source for pet dietary supplements, with specialty additives to mitigate the effect of aflatoxins in canines.”

    Source page · seen on

Services

  • Custom formulationShow quote“Our in-house labs are staffed by experienced product formulation teams who are ready to assist in product development and custom formulations.”
    “Our in-house labs are staffed by experienced product formulation teams who are ready to assist in product development and custom formulations.”

    Source page · seen on

  • Contract manufacturingShow quote“PreMark Health Sciences is a full-service contract manufacturer specializing in nutrition products and dietary supplements for humans and canine markets.”
    “PreMark Health Sciences is a full-service contract manufacturer specializing in nutrition products and dietary supplements for humans and canine markets.”

    Source page · seen on

  • TurnkeyShow quote“PreMark provides turnkey blending and manufacturing solutions for powders and capsules covering a variety of product categories.”
    “PreMark provides turnkey blending and manufacturing solutions for powders and capsules covering a variety of product categories.”

    Source page · seen on

  • Packaging & bottlingShow quote“We offer comprehensive packaging solutions including form-fill-seal, product assembly, pouching, labeling, and custom services tailored to your unique needs.”
    “We offer comprehensive packaging solutions including form-fill-seal, product assembly, pouching, labeling, and custom services tailored to your unique needs.”

    Source page · seen on

  • Stick packs & sachetsShow quote“Stickpacks and Sachets – Convenient, portable, and portion-controlled”
    “Stickpacks and Sachets – Convenient, portable, and portion-controlled”

    Source page · seen on

Product certifications it claims

  • Gluten-freeShow quote“GFCO Gluten Free Plant Registration #45457”
    “GFCO Gluten Free Plant Registration #45457”

    Source page · seen on

Commercial details

  • Lead time: 4-6 weeks (company website)Show quote“Typical turnaround 4-6 weeks after all components received.”
    “Typical turnaround 4-6 weeks after all components received.”

    Source page · seen on

We read the company’s public web pages and keep a claim only when its quote appears on the page. A claim is hidden once we haven’t seen it for 120 days. Spotted something wrong? Tell us · How we collect website claims

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 1 facility address
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.
  • What the company’s own website says it makes and offers, shown above with quotes

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026